Journals / The Journal of Pediatric Research / 2018 / Cilt: 5 - Sayı: 1

Persistent Hypertransaminasemia Uncovered Occult Limb-Girdle-Muscle Dystrophy-Type-2C in a Saudi Child

Pages
57–59
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This case demonstrates that increased transaminases do not always suggest liver disease, and occult muscle disease should always be taken into account while investigating patients with unexplained persistent hypertransaminasemia.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:An asymptomatic 4.5 years-old Saudi girl was referred to the pediatric hepatology service with presumed liver disease because of the persistently elevated transaminases which were discovered accidently during routine laboratory workup.
📊
Key Findings & Data:Alanine aminotransferase was 128 IU/L and aspartate aminotransferase was 143 IU/L.
💡
Conclusion & Impact:This case demonstrates that increased transaminases do not always suggest liver disease, and occult muscle disease should always be taken into account while investigating patients with unexplained persistent hypertransaminasemia.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

An asymptomatic 4.5 years-old Saudi girl was referred to the pediatric hepatology service with presumed liver disease because of the persistently elevated transaminases which were discovered accidently during routine laboratory workup. Alanine aminotransferase was 128 IU/L and aspartate aminotransferase was 143 IU/L. Subsequent investigations in the hepatology clinic revealed normal hepatic workup. Muscle related work up revealed increased creatine phosphokinase, abnormal electromyography and motor nerve conduction. Muscle biopsy was suggestive of early stage muscular dystrophy, and analyses were compatible with limb-girdle-muscle-disease Type 2C. Further confirmation was reached by molecular genetic testing. This case demonstrates that increased transaminases do not always suggest liver disease, and occult muscle disease should always be taken into account while investigating patients with unexplained persistent hypertransaminasemia.

🔖

Cite This Article

ESKANDER, A. E., RAFİQUE, M., KAMAL, N. M., EL-SHABRAWİ, M. H., ABİDİ, K., ALGHAMDİ, H. A., HALABİ, A., ALHARBİ, A. O., MANSOUR, H., SHERİEF, L. M. (2018). Persistent Hypertransaminasemia Uncovered Occult Limb-Girdle-Muscle Dystrophy-Type-2C in a Saudi Child. The Journal of Pediatric Research, Cilt: 5 - Sayı: 1, 57–59. https://ajindex.com/articles/362796

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Giannini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians. CMAJ 2005;172:367-79
  2. Nathwani RA, Pais S, Reynolds TB, Kaplowitz N. Serum alanine aminotransferase in skeletal muscle diseases. Hepatology 2005;41:380-2
  3. Papadimas GK, Areovimata A, Papadopoulos C, Manta P. Re: Consider muscle disease in children with elevated transaminase. J Am Board Fam Med 2012;25:937 4. Dibek Misirlioğlu E, Albayrak M, Aliefendioğlu D. Elevations of serum aminotransferase in muscular dystrophy. Turk J Gastroenterol 2008;19:202
  4. Kohli R, Harris DC, Whitington PF. Relative elevations of serum alanine and aspartate aminotransferase in muscular dystrophy. J Pediatr Gastroenterol Nutr 2005;41:121-4
  5. Lash T, Kraemer RR. Elevated liver enzymes indicating a diagnosis of limb-girdle muscular dystrophy. J Gen Intern Med 2014;29:813-5
  6. McMillan HJ, Gregas M, Darras BT, Kang PB. Serum transaminase levels in boys with Duchenne and Bucker muscular dystrophy. Pediatrics 2011;127:132-6
  7. Wright MA, Yang ML, Parsons JA, Westfall JM, Yee AS. Consider muscle disease in children with elevated transaminase. J Am Board Fam Med 2012;25:536-40
  8. Lin YC, Lee WT, Huang SF, Young C, Wang PJ, Shen YZ. Persistent hypertransaminasemia as the presenting finding of muscular dystrophy in childhood. Acta Paediatr Taiwan 1999;40:424-9.